检索结果-南通市图书馆

Prevalence and treatment patterns of ranibizumab and photodynamic therapy in a tertiary care setting in Malaysia

International Journal of Ophthalmology(English edition) 2017年第12期10卷 1889-1897页

作者： Nur Afiqah Mohamad Vasudevan Ramachandran Patimah Ismail Hazlita Mohd lsa Yoke Mun Chan Nor Fariza Ngah norshakimah md bakri Siew Mooi Ching Fan Kee Hoo Wan Aliaa Wan Sulaiman Malaysian Research Institute on Ageing Universiti PutraMalaysiaSerdangSelangor DE 43400Malaysia Department of Biomedical Science Faculty of Medicine andHealth SciencesUniversiti Putra MalaysiaSerdangSelangorDE 43400Malaysia Department of Ophthalmology Universiti KebangsaanMalaysia Medical CentreCherasKuala Lumpur 56000Malaysia Department of Nutrition and Dietetics Faculty of Medicineand Health SciencesUniversiti Putra MalaysiaSerdangSelangor DE 43400Malaysia Department of Ophthalmology Hospital SelayangLebuhrayaSelayang-KepongBatu Caves 68100Malaysia Department of Family Medicine Faculty of Medicine andHealth SciencesUniversiti Putra MalaysiaSerdangSelangorDE 43400Malaysia Department of Medicine Faculty of Medicine and HealthSciencesUniversiti Putra MalaysiaSerdangSelangor DE43400Malaysia

AIM：To describe the prevalence and changes in treatment patterns of ranibizumab and photodynamic therapy（PDT） among retinal disease patients who attended the Ophthalmology Clinic in the tertiary care Hospital Selayang from 2010 to ***：Study subjects were recruited retrospectively using the Electronic Medical Record（EMR） database software in Hospital *** data,medical history,diagnostic procedure,treatments and diagnosis of patients were ***：The five-year analysis included 821 patients with a mean age of 65.9±11.73 ***,there were a highernumber of males（63.1%） and a higher number of Chinese（47.4%） *** the 821 patients,62.9% received ranibizumab injection followed by 19.2% PDT therapy and 17.9% had ranibizumab combined with PDT ***-related macular degeneration（Amd） and polypoidal choroidal vasculopathy（PCV） were the most common retinal eye diseases reported,recording prevalence of 25.0% and 45.6%,*** trend in ranibizumab treatment was reported to increase while PDT showed a decrease in trend from year 2010 to *** terms of treatment,following multiple logistic regression,Amd was associated with the subjects being more likely to have received ranibizumab monotherapy（P〈0.001） while PCV was associated with more likely to have received PDT（P〈0.001） and PDT combined with ranibizumab therapy（P〈0.001）.CONCLUSION：The tertiary care setting in Malaysia is consistent with management of patients from other countries whereby ranibizumab is the most common treatment given to patients with Amd,while PCV patients most commonly receive PDT and ranibizumab combined with PDT therapy.

关键词： anti-vascular endothelial growth factor therapy photodynamic therapy ranibizumab treatment patterns

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：